AdaptHealth
AHCO
152 hedge funds and large institutions have $2.15B invested in AdaptHealth in 2021 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 57 increasing their positions, 45 reducing their positions, and 17 closing their positions.
76% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 17
28% more capital invested
Capital invested by funds: $1.68B → $2.15B (+$469M)
27% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 45
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
11.52% more ownership
Funds ownership: 55.17% → 66.69% (+12%)
7% more funds holding
Funds holding: 142 → 152 (+10)
47% less call options, than puts
Call options by funds: $2.67M | Put options by funds: $5.03M
Top Buyers
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$9.74M |
| 2 |
MFIMFI
Mesirow Financial Investment Management - Fixed Income
Chicago,
Illinois
|
-$8.22M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$7.81M |
| 4 |
KLC
Kent Lake Capital
Reno,
Nevada
|
-$5.05M |
| 5 |
AC
Armistice Capital
New York
|
-$4.41M |
AHCO Hedge Fund Activity: Q4 2021 in Review
152 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in AdaptHealth (AHCO) for Q4 2021, worth a combined $2.15B — up 28% from $1.68B a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new AHCO positions and 17 closed out — a net gain of 13 holders — while 57 added to existing stakes and 45 trimmed.
The largest buyer was Deerfield Management, adding an estimated $49.8M. The largest seller was UBS Group, cutting an estimated $9.74M.
- 152 institutional investors held AdaptHealth (AHCO) as of Q4 2021, up from 142 in Q3 2021.
- Funds reported $2.15B of AdaptHealth stock for Q4 2021, up 28% quarter-over-quarter.
- 30 funds opened new AdaptHealth positions in Q4 2021 and 17 closed out, a net change of +13 holders.
- The largest AdaptHealth buyer in Q4 2021 was Deerfield Management, an estimated $49.8M added.
- The largest AdaptHealth seller in Q4 2021 was UBS Group, an estimated $9.74M sold.
Based on aggregated 13F filings for Q4 2021.